Application Nr Approved Date Route Status External Links
ANDA040069 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For The Treatment Of The Following Conditions: Ophthalmic: Steroid Responsive Inflammatory Conditions Of The Palpebral And Bulbar Conjunctiva, Cornea, And Anterior Segment Of The Globe, Such As Allergic Conjunctivitis, Acne Rosacea, Superficial Punctate Keratitis, Herpes Zoster Keratitis, Iritis, Cyclitis, Selected Infective Conjunctivitis When The Inherent Hazard Of Steroid Use Is Accepted To Obtain An Advisable Diminution In Edema And Inflammation; Corneal Injury From Chemical Or Thermal Burns, Or Penetration Of Foreign Bodies. Otic: Steroid Responsive Inflammatory Conditions Of The External Auditory Meatus, Such As Allergic Otitis Externa, Selected Purulent And Nonpurulent Infective Otitis Externa When The Hazard Of Steroid Use Is Accepted To Obtain An Advisable Diminution In Edema And Inflammation.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dexamethasone Sodium Phosphate DEXAMETHASONE SODIUM PHOSPHATE ZINC4654654

Comments